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Abstract: By using deceptive experiments in which participants are informed that they received
caffeine when, in fact, they received an inert substance (i.e., placebo), several investigations have
demonstrated that exercise performance can be enhanced to a similar degree as a known caffeine dose.
This ‘placebo effect’ phenomenon may be part of the mechanisms explaining caffeine’s ergogenicity
in exercise. However, there is no study that has established whether the placebo effect of caffeine is
also present for other benefits obtained with acute caffeine intake, such as enhanced fat oxidation
during exercise. Therefore, the aim of this investigation was to investigate the placebo effect of
caffeine on fat oxidation during exercise. Twelve young men participated in a deceptive double-
blind cross-over experiment. Each participant completed three identical trials consisting of a step
incremental exercise test from 30 to 80% of
.
VO2max. In the two first trials, participants ingested
either 3 mg/kg of cellulose (placebo) or 3 mg/kg of caffeine (received caffeine) in a randomized
order. In the third trial, participants were informed that they had received 3 mg/kg of caffeine, but
a placebo was provided (informed caffeine). Fat oxidation rates were derived from stoichiometric
equations. In received caffeine, participants increased their rate of fat oxidation over the values
obtained with the placebo at 30%, 40%, 50%, and 60% of
.
VO2max (all p < 0.050). In informed caffeine,
participants increased their rate of fat oxidation at 30%, 40%, 50% 60%, and 70% of
.
VO2max (all
p < 0.050) over the placebo, while there were no differences between received versus informed
caffeine. In comparison to placebo (0.32 ± 0.15 g/min), the rate of maximal fat oxidation was higher
in received caffeine (0.44 ± 0.22 g/min, p = 0.045) and in informed caffeine (0.41 ± 0.20 g/min,
p = 0.026) with no differences between received versus informed caffeine. However, the intensity
at which maximal fat oxidation rate was obtained (i.e., Fatmax) was similar in placebo, received
caffeine, and informed caffeine trials (42.5 ± 4.5, 44.2 ± 9.0, and 41.7 ± 10.5% of
.
VO2max, respectively,
p = 0.539). In conclusion, the expectancy of having received caffeine produced similar effects on
fat oxidation rate during exercise than actually receiving caffeine. Therefore, the placebo effect of
caffeine is also present for the benefits of acute caffeine intake on substrate oxidation during exercise
and it may be used to enhance fat oxidation during exercise in participants while reducing any risks
to health that this substance may have.
Keywords: dietary supplement; ergogenic aid; psychological advantage; carbohydrate
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1. Introduction
Caffeine is considered as a potent ergogenic aid with the capacity of increasing perfor-
mance in a wide spectrum of exercise and sports [1–3]. For this reason, caffeine is broadly
consumed before exercise in doses from 3 to 9 mg per kg of body mass [4] (i.e., mg/kg) in
the form of coffee or tea (natural sources) or in capsules/pills, pre-workout supplements,
energy drinks, and caffeinated gums (artificial sources) [5]. Although less-well studied,
acute caffeine intake can also produce a shifting in substrate oxidation during exercise
when ingested in doses similar to the ones used for performance enhancement [6,7]. Briefly,
pre-exercise ingestion of caffeine has the capacity to increase fat oxidation rate during
incremental [8] and steady-state exercise [9] while it concomitantly reduces carbohydrate
utilization. The capacity of caffeine to shift substrate oxidation is habitually found at
low-to-moderate exercise intensities, which limits its effectiveness when performing near-
to-maximal intensity exercise [6,10]. Although enhanced fat utilization probably adds
little to caffeine’s ergogenicity in most sport situations, the utilization of caffeine prior to
endurance exercise may benefit those enrolled in exercise programs for body weight loss.
Overall, there is ample consensus to consider antagonism on adenosine receptors as the
main mechanism behind caffeine’s ergogenicity [11] while the lipolytic action of caffeine
may also contribute to its effects on substrate oxidation [12].
Interestingly, several recent investigations have suggested that the belief of having
ingested caffeine without actually ingesting the substance, may increase exercise perfor-
mance [13–17] suggesting that positive expectations of receiving caffeine can add to the
pharmacological actions of caffeine [18]. This phenomenon, known as the placebo effect
of caffeine, is enabled by the endogenous release of opioids and non-opioids, and it has
been found for other active substances [19]. However, two factors are specific for caffeine:
first, a high portion of the world population consumes or has consumed caffeine and they
have likely experienced the stimulating effects that this substance produces; second the
performance-enhancement properties of caffeine are well-known, and individuals expect
higher performance when they are told that have ingested caffeine. However, to date, no
previous investigation has established whether the placebo effect of caffeine is also present
for enhanced fat oxidation during exercise.
The purpose of this experiment was to investigate the placebo effect of caffeine on
fat oxidation during exercise. We hypothesized that participants would have increased
fat oxidation during exercise when they are told that they had received caffeine. How-
ever, we also hypothesized that the placebo effect of caffeine would be lower than the
pharmacological effect of acute caffeine ingestion.
2. Materials and Methods
2.1. Participants
Twelve young male participants volunteered to participate in the study (age = 23 ± 5
years, body mass = 69.0 ± 10.6 kg, height =1.77 ± 0.06 m, body fat = 9.4 ± 3.5%, and
maximal oxygen uptake (
.
VO2max) = 56.2 ± 7.7 mL/kg/min). An a priori sample size
calculation indicated that 12 participants were needed to obtain statistically significant
differences in maximal fat oxidation rate with three mg of caffeine per kg of body mass
respect to the placebo. This a priori sample size was calculated to obtain an effect size of
1.01 in Cohen’s d units (statistical power of 80% with type I error set at 5%), based on a
previous investigation that obtained this effect when using the same dose of caffeine during
an incremental exercise test [8]. The required sample size was determined using G*Power
software [20]. The following inclusion criteria were established for potential participants:
(a) age between 18 and 40 years; (b) regular exercise training of >1 h per day, >4 days per
week for the prior six months; and (c) low daily caffeine consumption [21]. The following
exclusion criteria were applied to potential participants: (a) lower limb injury within the
prior two months; (b) smoking; (c) use of any type of medication or dietary supplement
in the previous month; (d) history of cardiopulmonary, metabolic, or musculoskeletal
diseases; or (e) allergy to caffeine. Participants were notified in detail of all experimental
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procedures, potential risks and discomforts associated with the experiment before they
signed an informed written consent. The study was approved by the Francisco de Vitoria
University Research Ethics Committee (18-2020) and was conducted in accordance with
the last version of the Declaration of Helsinki.
2.2. Experimental Design
A deceptive, double-blind and cross-over design was used for this investigation. Each
participant underwent three trials separated by three-to-five days. The time between
trials was set to permit complete physical recovery and substance elimination [22], while
reducing the effect of physical training in the experiments (i.e., less than ten days between
the first and last trial). In the two first trials, and in a randomized order, participants
ingested either 3 mg/kg of body mass of a placebo (cellulose, Guinama, Spain) or 3 mg/kg
of body mass of caffeine (Bulk Powders, London, United Kingdom). We selected 3 mg/kg
of caffeine because we have recently found that this dose is effective in enhancing fat
oxidation during incremental [8] and steady-state exercise [9] in individuals with low
habitual caffeine consumption. In the third trial, participants ingested a placebo, but they
were informed that they had received 3 mg/kg of caffeine. Initially, participants were
informed that they would take part in two experimental trials investigating the effects of
caffeine on fat oxidation during exercise. Once the two first two trials were completed,
they were told about the need to perform a third trial because the data during the tests
with caffeine had not been recorded. Therefore, with this deceptive model, participants
had the expectancy of having received caffeine in the third trial. Before the onset of the
experiment, participants were informed about the findings of research related to acute
effects of caffeine intake on fat oxidation rate through the written informed consent and
informal conversations during the recruiting process. This was to create the belief in
participants that caffeine has a well-proven capacity to increase fat oxidation during
exercise. In all trials, participants ingested an opaque capsule 60 min before the onset of
the experimental trials. All tests were performed in a laboratory under controlled ambient
conditions (21.7 ± 0.9 ◦C of dry temperature and 41.4 ± 6.0% of relative humidity).
2.3. Pre Experimental Trial
One week before the first trial, participants were weighed to calculate caffeine and
placebo dosing and body fat was calculated by bioimpedance (Tanita InnerScan Dual,
RD-901BK36, Tokyo, Japan). Then, participants underwent a standardized warm-up that
included 10-min at 50 W on a cycle ergometer (Ergoselect 4, Ergoline, Bitz, Germany).
Afterwards, participants performed a step incremental exercise test on the cycle ergometer
to measure
.
VO2max. The test started with a workload of 75 W and it was set a progressive
increase of 25 W each min until volitional fatigue. During the test, participants chose a
cadence between 70 and 90 rpm. The test was finished when participants were unable to
maintain a cadence above 50 rpm. Oxygen uptake (
.
VO2) and carbon dioxide production
(VCO2) were measured during the incremental exercise test by using a breath-by-breath gas
analyser (Ergostik, Geratherm Respiratory, Bad Kissingen, Germany). The step incremental
exercise test was considered maximal when all four end criteria for
.
VO2max were reached
at the end of the tests: (i)
.
VO2 maintenance despite increases in ergometric power, (ii)
respiratory exchange ratio above 1.10, (iii) rating of perceived fatigue above 19 points
by using the 6–20-point Borg scale [23], and (iv) peak heart rate superior to 90% of age-
predicted maximal heart rate (i.e., 220-age).
.
VO2max was defined as the highest
.
VO2 value
obtained during the test, once the data had been averaged by using 15-s intervals. Exercise
intensity was normalized in the subsequent experimental trials by using 10% increases of
.
VO2max. For this normalization, a regression analysis was performed for each participant
for the relationship between wattage and
.
VO2 obtained in this pre-experimental test.
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2.4. Experimental Protocol
Twenty-four hours before each experimental trial, participants refrained from ex-
hausting exercise and adopted a food intake and fluid intake regimen as they are would
do before a sport competition. Fluid and diet guidelines were provided to increase the
likelihood of carbohydrate availability [24] and euhydration [25] before all experimental
trials. Participants were also required to avoid alcohol, caffeine, and other stimulants for
24 h before each trial. To produce a within-subject standardization of diet, participants
completed a 24-h dietary record before the first trial, and they replicated the same dietary
pattern before the second and third trials. In each trial, participants were encouraged to
abstain from any food for >8 h before the trial (last meal was dinner at 21.00 the night be-
fore) and they arrived at the laboratory in a fasted state. Participants were told of the need
for drinking ~7 mL/kg of water in the two-hour period before arriving to the laboratory
(08.00 am) to assure euhydration. Upon arrival, a urine sample was obtained to assess
euhydration, which was confirmed by a urine specific gravity (MASTER-S28M, Atago
Company, Tokyo, Japan) < 1.020 [26]. Then, the capsule with the assigned experimental
treatment was consumed with 150 mL of tap water while an experimenter certified this pro-
cess. After that, participants rested for 1 h to permit substance absorption. In the last five
minutes of the resting period, heart rate (Wearlink, Polar, Kempele, Finland) and systolic
and diastolic blood pressure (M6 Comfort, Omron, Kyoto, Japan) were measured while
the participants lay on a stretcher. Then, participants completed a 10-min standardized
warm-up at a workload equivalent to 30% of
.
VO2max, as measured in the pre experimental
session (Ergoselect 4, Ergoline, Bitz, Germany). Once the warm-up was completed, par-
ticipants were told that the exercise test had started, and they were not allowed to speak
during the whole trial (unless an emergency occurred). The experimental test consisted
of a step incremental exercise with 10%
.
VO2max increases every 3-min. The test finalized
once participants had completed the workload equivalent to 80% of
.
VO2max because the
respiratory exchange ratio was above 1.00 in all participants. At the end of each stage,
participants were asked about their perceived fatigue by using the 6–20-point Borg scale.




VCO2 (Ergostik, Geratherm Respiratory, Bad Kissingen, Germany). During the
last minute of each stage, participants were instructed to maintain a stable position and
cadence and gas exchange data and heart rate were averaged to achieve a representative
value for each exercise intensity level. At each stage, energy expenditure and fat and














VCO2 are in L/min. Fat oxidation rate (in g/min) was
calculated as (1.67 ×
.
VO2) − (1.67 ×
.
VCO2) and carbohydrate oxidation rate (in g/min)
was calculated as (4.55 ×
.
VCO2) − (3.21 ×
.
VO2). Maximal fat oxidation rate was estab-
lished for each participant as the maximum value of fat oxidation rate obtained at any stage
during the incremental exercise test [29]. The exercise intensity that produced maximal fat
oxidation rate was established as Fatmax. Both maximal fat oxidation rate and Fatmax were
individually calculated for each participant in each trial by two investigators blinded to
the treatments. The position of the saddle and handlebar in the cycle ergometer, cadence
in all stages, and the clothing used was replicated in all trials. At the end of the first
two experimental trials, participants were asked to guess in which trial they had received
caffeine.
2.5. Statistical Analysis
The results of each test were introduced into the statistical package SPSS v 22.0 (IBM
Corp., Armonk, NY, USA) and analyzed by a researcher blinded to the treatments. The
normality of each variable was initially tested with the Shapiro–Wilk test, and, consequently,
parametric statistics tests were used to determine differences among trials. The data are
presented as mean ± standard deviation. A one-way analysis of variance (ANOVA) was
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used to detect differences in maximal fat oxidation rate, Fatmax, and the values obtained
at test (i.e., heart rate, blood pressure, and urine specific gravity). A two-way analysis of
variance (substance × exercise intensity) was used to determine difference in the variables
obtained during the step incremental exercise test. After a significant F test was obtained,
differences were identified by Bonferroni post-hoc tests. In all statistical tests, a level of
p < 0.050 was set to establish statistically significant differences.
3. Results
3.1. Pre-Exercise Heart Rate, Blood Pressure and Urine Specific Gravity
There was no main effect of substance on resting heart rate, blood pressure variables,
or urine specific gravity (Table 1).
Table 1. Variables obtained at test in individuals who ingested (1) a placebo; (2) three mg of caffeine
per kg of body mass (received caffeine); and (3) a placebo, but they were told they were given three
mg of caffeine per kg mass (informed caffeine).
Variable (Units) Placebo ReceivedCaffeine
Informed
Caffeine p
Resting heart rate (beat/min) 53 ± 8 52 ± 8 53 ± 9 0.509
Systolic blood pressure (mmHg) 116 ± 12 119 ± 9 117 ± 9 0.639
Diastolic blood pressure (mmHg) 66 ± 10 68 ± 7 66 ± 6 0.191
Urine specific gravity 1.013 ± 0.006 1.014 ± 0.005 1.017 ± 0.003 0.271
3.2. Substrate Oxidation, Energy Expenditure, Heart Rate, and Exertion during the Step
Incremental Test
For the two first trials, only five out of 12 participants (41.7%) correctly guessed when
they had received caffeine. There were main effects of substance (F = 4.43, p = 0.024) and
exercise intensity (F = 17.06, p < 0.001) on the rate of fat oxidation during exercise, with a
statistically significant interaction between these two factors (F = 2.34, p = 0.015). The post-
hoc analysis revealed that “received caffeine” trial increased the rate of fat oxidation over
the values obtained with the placebo at 30%, 40%, 50%, and 60% of
.
VO2max (all p < 0.050;
Figure 1). The “informed caffeine” trial increased the rate of fat oxidation by 30%, 40%, 50%
60%, and 70% of
.
VO2max (all p < 0.050), while there were no differences between received
caffeine and informed caffeine. For carbohydrate oxidation rate during exercise, there
was a main effect of exercise intensity (F = 127.99, p < 0.001) and a substance × intensity
interaction (F = 2.29, p = 0.048). The post-hoc analysis revealed that only informed caffeine
reduced carbohydrate oxidation rates at 40% and 50% of
.
VO2max (all p < 0.050).




Figure 1. (a) Fat oxidation rate and (b) carbohydrate oxidation rate during an incremental step 
exercise test on a cycle ergometer in active individuals who ingested (1) a placebo; (2) three mg of 
caffeine per kg of body mass (received caffeine); and (3) a placebo, but they were told they were 
given three mg of caffeine per kg mass (informed caffeine). (*) Received caffeine different from 
placebo for the same workload at p < 0.050. (†) Informed caffeine different from placebo for the 
same workload at p < 0.050. 
There was a main effect of exercise intensity (F = 480.58, p < 0.001) and a substance × 
intensity interaction (F = 2.49, p = 0.039) in the rate of energy expenditure. However, the 
post-hoc analysis did not reveal any statistically significant difference in the pairwise com-
parison between experimental trials at any workload. For heart rate, there was only a main 
effect of exercise intensity (F = 95.85, p < 0.001) with no post-hoc differences (Figure 2). 
 
Figure 2. (a) Energy expenditure rate and (b) heart rate during an incremental step exercise test on 
a cycle ergometer in active individuals who ingested (1) a placebo; (2) three mg of caffeine per kg 
of body mass (received caffeine); and (3) a placebo, but they were told they were given three mg of 
caffeine per kg mass (informed caffeine). 
There were main effects of substance (F = 5.72, p = 0.008) and exercise intensity (F = 
35.95, p < 0.001) in the rating of perceived exertion during exercise, although the interac-
tion between these two factors did not reach statistical significance (F = 1.56, p = 0.189). 
The post-hoc analysis revealed that “received caffeine” decreased the rating of perceived 
exertion at 30% and 40% of VO2max (all p < 0.050; Figure 3) with no other differences in the 
remaining workloads between experimental trials. 
Figure 1. (a) F xidatio rate nd (b) c rbohydrate oxi at on rate during an incremental step exercise
test on a cycle ergometer in active individuals who ingested (1) a placebo; (2) three mg of caffeine per
kg of body mass (received caffeine); and (3) a placebo, but they were told they were given three mg
of caffeine per kg mass (informed caffeine). (*) R ceived caffeine different from placebo for the same
workload at p < 0.050. (†) Informed caffeine different from placebo for the same workload at p < 0.050.
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There was a main effect of exercise intensity (F = 480.58, p < 0.001) and a substance
× intensity interaction (F = 2.49, p = 0.039) in the rate of energy expenditure. However,
the post-hoc analysis did not reveal any statistically significant difference in the pairwise
comparison between experimental trials at any workload. For heart rate, there was only a
main effect of exercise intensity (F = 95.85, p < 0.001) with no post-hoc differences (Figure 2).
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was no main effect of substance on Fatmax (F = 0.66, p = 0.539) and Fatmax value was similar 
in the placebo, received caffeine, and informed caffeine trials (42.5±4.5, 44.2±9.0, and 
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The purpose of the current study was to determine the existence of the placebo effect 
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Figure 3. Rating of perceived exertion, measured with the Borg scale during an incremental step
exercise test on a cycle ergometer in active individuals who ingested (1) a placebo; (2) three mg of
caffeine per kg of body mass (received caffeine); and (3) a placebo, but they were told they were given
th e mg of ca feine per kg mass (informed caffein ). (*) Received caffeine different from placebo for
the sa e workload at p < 0.050.
3.3. Maximal Fat Oxidation Rate and Fatmax
There was a main effect of substance on maximal fat oxidation rate during exercise
(F = 6.31, p = 0.007). In comparison to placebo (0.32 ± 0.15 g/min), the rate of maximal fat
oxidation was higher in received caffeine (0.44 ± 0.22 g/min, p = 0.045) and in informed
caffeine (0.41 ± 0.20 g/min, p = 0.026). From the total, six participants obtained the highest
value of maximal fat oxidation in the trial with received caffeine, five participants in the
informed caffeine trial and one participant in the placebo trial (Figure 4). However, there
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was no main effect of substance on Fatmax (F = 0.66, p = 0.539) and Fatmax value was similar
in the placebo, received caffeine, and informed caffeine trials (42.5 ± 4.5, 44.2 ± 9.0, and
41.7 ± 10.5% of
.
VO2max, respectively).




Figure 3. Rating of perceived exertion, measured with the Borg scale during an incremental step 
exercise test on a cycle ergometer in active individuals who ingested (1) a placebo; (2) three mg of 
caffeine per kg of body mass (received caffeine); and (3) a placebo, but they were told they were 
given three mg of caffeine per kg mass (informed caffeine). (*) Received caffeine different from 
placebo for the same workload at p < 0.050. 
3.3. Maximal Fat Oxidation Rate and Fatmax 
There was a main effect of substance on maximal fat oxidation rate during exercise 
(F = 6.31, p = 0.007). In comparison to placebo (0.32 ± 0.15 g/min), the rate of maximal fat 
oxidation was higher in received caffeine (0.44 ± 0.22 g/min, p = 0.045) and in informed 
caffeine (0.41 ± 0.20 g/min, p = 0.026). From the total, six participants obtained the highest 
value of maximal fat oxidation in the trial with received caffeine, five participants in the 
informed caffeine trial and one participant in the placebo trial (Figure 4). However, there 
was no main effect of substance on Fatmax (F = 0.66, p = 0.539) and Fatmax value was similar 
in the placebo, received caffeine, and informed caffeine trials (42.5±4.5, 44.2±9.0, and 
41.7±10.5% of VO2max, respectively). 
 
Figure 4. Individual responses for maximal fat oxidation rate during an incremental step exercise 
test on a cycle ergometer in active individuals who ingested (1) a placebo; (2) three mg of caffeine 
per kg of body mass (received caffeine); and (3) a placebo, but they were told they were given 
three mg of caffeine per kg mass (informed caffeine). Each dot represents one participant. (*) Re-
ceived caffeine different from placebo at p < 0.050. (†) Informed caffeine different from placebo at p 
< 0.050. 
4. Discussion 
The purpose of the current study was to determine the existence of the placebo effect 
of caffeine on fat oxidation during exercise. This was based on previous investigations 
Figure 4. Individual responses for maximal fat oxidation rate during an incremental step exercise
test on a cycle ergometer in active individuals who ingested (1) a placebo; (2) three mg of caffeine per
kg of body mass (received caffeine); and (3) a placebo, but they were told they were given three mg
of caffeine per kg mass (informed caffeine). Each dot represents one participant. (*) Received caffeine
different from placebo at p < 0.050. (†) Informed caffeine different from placebo at p < 0.050.
4. Discussion
The purpose of the current study was to determine the existence of the placebo effect
of caffeine on fat oxidation during exercise. This was based on previous investigations
that have found a placebo effect of caffeine on exercise performance [13–17] and have
suggested that the expectancy of having received caffeine may induce a placebo-induced
performance-enhancement. The main outcomes of this investigation confirm the existence
of the placebo effect of caffeine on fat oxidation during exercise as participants increased
fat oxidation to a similar extent when they received three mg/kg of caffeine and when
they were informed that they had received this dose of caffeine, although a placebo was
administered (Figure 1). Specifically, both trials, received caffeine and informed caffeine,
increased the rate of fat oxidation over the placebo when exercising at 30%, 40%, 50%,
and 60% and the magnitude of the change in maximal fat oxidation was comparable.
Additionally, Figure 4 reveals that the pharmacological and placebo effect of caffeine on
maximal fat oxidation rate was present in most of the individuals of this sample (11 out
of 12), suggesting that these effects can be widely found in recreational male individuals.
Collectively, this investigation indicates that the expectancy of having received caffeine
was equally effective to the real administration of caffeine on fat oxidation during exercise
and suggests that the placebo effect of caffeine may be used to produce a higher utilization
of fat during exercise under certain circumstances.
The placebo effect is a phenomenon that occurs when an inert substance is given
instead an active medication, but individuals are convinced that they had received the
active substance. This belief habitually induces positive outcomes that are attributable
to the psychosocial context and individual treatment expectations [19] which creates
drug-like effects induced by the release of opioids and nonopioids. The placebo effect
of caffeine has been reported in the literature as a performance-enhancing strategy for
several forms of exercise such as endurance performance [15,16], muscle performance [13],
anaerobic performance [14], and skill-specific sport situations [30], although the placebo
effect of caffeine has not been found in all investigations on this topic [17,31]. In most of
these investigations, researchers have used deceptive experiments where participants are
informed of that they had received an ergogenic dose of caffeine to induce expectancy
when in fact, they were administered a placebo. The performance obtained in this trial (i.e.,
informed caffeine) is habitually compared to a real placebo/control situation and to a trial
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where participants actually received caffeine (i.e., received caffeine) [32]. However, recent
investigations [15,30] have introduced more complex experiments where expectancy and
the physiological effect of caffeine are dissociated by using four trials combining informed
caffeine/received caffeine, informed caffeine/received placebo, informed placebo/received
caffeine, and informed placebo/received placebo. In these latter investigations, it was not
clearly observed that combining expectancy with caffeine intake produced a synergistic
action on exercise performance.
The current experiment followed a two-phase protocol to induce expectancy as the
effect of caffeine to enhance fat oxidation is less well popular than the effect of caffeine
on exercise performance. We used such an approach as the knowledge of the potential
effect of the substance is essential to induce an effective placebo effect. Initially, we set
a double-blinded, randomized, and placebo-controlled experiment with two trials, in
which the efficacy of acute caffeine intake (received caffeine) to enhance fat oxidation
during an incremental step exercise was compared to a placebo trial, following a previous
investigation [8]. We used this initial phase to confirm the physiological effect of caffeine
on fat oxidation in our participants, as in these two trials participants did not receive any
information about the order of the substances ingested. In addition, the physiological
effect of caffeine was effectively isolated from the placebo effect as only 41.7% of the
participants correctly guessed when they had received caffeine. The second phase of the
experiment included a third trial where participants were told that they were given caffeine,
but a placebo was administered (informed caffeine). This phase was conducted after the
first phase to assure that participants have experienced the use of caffeine during low-to-
moderate exercise intensity, with the ultimate purpose of inducing a real expectancy about
caffeine-effect on fat oxidation. In addition, with this two-phase approach, participants
were unaware of the objective of the investigation and therefore, they were not conditioned
to guess what substance they had ingested in the third trial. In this experiment, we found
that the physiological effect of caffeine to increase fat oxidation rate during exercise was
similar to the placebo effect of caffeine on this variable, induced by the expectancy of
having received caffeine. These data confirm the existence of a psychological-induced
effect on fat utilization during exercise when participants believe that they had ingested
caffeine.
The mechanism(s) explaining higher fat oxidation in the informed caffeine trial vs.
placebo trial is/are not evident from our investigation. However, previous investigations
have suggested various mechanisms that may explain the findings of this study. First, it
has been speculated that the placebo effect on exercise performance may be the result of
participants adopting a more stable pacing strategy when they believed that had received
an active treatment [32]. Nevertheless, this mechanism seems not applicable to the current
experiment as the exercise workload and cadence were replicated in all trials. The most
probable explanation for the increased fat oxidation in the informed caffeine trial may be
related to neurobiological mechanisms associated with the placebo effect and expectancy.
The placebo effect has been associated with opioid, endocannabinoid, serotonin, and
dopamine systems while the most common view is that various neurotransmitter systems
are in fact involved at the same time in the placebo effect [33]. This especially applies to
the placebo effect of caffeine, as the main effect of this substance on the brain is to block
adenosine receptors, resulting in higher concentrations of serotonin, dopamine, and nore-
pinephrine [34]. Additionally, it has been suggested that the placebo effect often activates
the same pathways as the drug that it purports to be [35], suggesting then the placebo
effect of caffeine may increase the concentration of the same neurotransmitters as the actual
ingestion of caffeine. In this regard, the endogenous opioids and endocannabinoid system
are implicated in pain mechanisms and analgesia, the serotonin system is associated with
anxiety while dopamine has been investigated in the context of motivation [32]. There-
fore, it is possible that the expectancy of having received caffeine produces lower pain
and anxiety and enhances motivation during exercise. As the brain produces an effective
control mechanism to regulate exercise intensity, fatigue, and even metabolism [36], the
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change in the level neurotransmitters induced by the placebo effect of caffeine may entail
neurobiological mechanisms that facilitates changes in substrate oxidation. At this stage,
this is a speculation that needs confirmation in further experiments.
The placebo effect of caffeine on fat oxidation during exercise was accompanied by
other interesting placebo-induced changes. There was a substance × intensity interaction
for carbohydrate oxidation rate (Figure 1). However, the only statistically significant
differences in the pairwise comparison to the placebo trial were obtained in the informed
caffeine trial at 40 and 50% of
.
VO2max. Additionally, the three trials produced similar
values for energy expenditure and heart rate across the exercise intensity range used in
this investigation, although perceived exertion at low exercise intensities was only reduced
with the actual ingestion of caffeine (Figure 3). This means that participants did not feel
reduced fatigue in informed caffeine, despite this being a habitual physiological effect of
the placebo effect of caffeine [37]. All this information suggests that the placebo effect may
induce additional changes to enhanced fat oxidation during exercise of low-to-moderate
intensity such as reduced carbohydrate utilization, while the shifting in substrate oxidation
is evident without measurable effect on energy expenditure, heart rate, or perceived fatigue.
The deceptive experimental design used for this investigation has several limitations.
The first two experimental trials were performed in a double-blinded and randomized
fashion and the percentage of participants who correctly guessed when they had received
caffeine suggests that the blinding procedure was successful. However, the informed
caffeine trial was always performed after these two initial trials. This was selected to
generate a protocol that undoubtedly produced expectancy of receiving caffeine and the
potential belief in caffeine-induced effects on substrate oxidation, but this may have gener-
ated an order effect in the outcomes of this investigation. Second, the current investigation
was performed during an incremental step test in recreationally active male participants.
Therefore, the outcomes of this investigation can only be translated to male individuals
during exercise of increasing intensity. The confirmation of the placebo effect of caffeine
in enhancing fat oxidation during exercise has to be tested in women, during steady state
exercise, and in athletes with a higher training background. Additionally, participants in
this study were individuals with a low level of daily caffeine consumption. It is probable
that the placebo effect of caffeine on fat oxidation during exercise is lower or even inexistent
in habitual caffeine consumers, as has been recently found for muscle performance [17].
Third, a recent meta-analysis indicated that the ability of caffeine to increase fat oxidation
during exercise is higher in doses ≥ 6 mg/kg when compared to ~3 mg/kg [6]. Future
investigations should determine if the expectancy of having received a dose of 6 mg/kg of
caffeine also produces a higher effect on fat oxidation during exercise than the expectancy
of receiving 3 mg/kg. Fourth, the trials received caffeine and informed caffeine established,
independently, the physiological effect of caffeine and expectancy of receiving caffeine,
respectively. However, it is still possible that both effects can have a synergistic action when
participants are given caffeine and they are told that they receive caffeine (i.e., received
caffeine + informed caffeine). Further investigations with this experimental approach are
needed to confirm this hypothesis, although it seems that combining the physiological
effect of caffeine and expectancy does not produce a synergistic ergogenicity [15], or the ef-
fect is slightly higher than the isolated effects of these two strategies [38]. Last, no biological
markers relating to mechanistic actions associated with the placebo effect of caffeine were
measured. Recently, it has been proposed that that mechanisms associated with the placebo
effect of caffeine may mimic real mechanisms associated to acute caffeine intake [32]. There-
fore, the measurement of plasma glycerol and free fatty acid concentration [39], and muscle
oxygen saturation [40] in future investigations may help to determine the mechanism
associated with the placebo effect of caffeine on fat oxidation during exercise. Finally, the
current investigation demonstrates the existence of the placebo effect of caffeine on fat
oxidation during exercise when the individuals believed that they had ingested a dose of
3 mg/kg of caffeine.
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5. Conclusions
The findings of the current investigation suggest that expectancy of having received
caffeine produces similar effects on fat oxidation rate during exercise to receiving caffeine.
Therefore, the placebo effect of caffeine is also present for the benefits of acute caffeine
intake on substrate oxidation during exercise. From a practical perspective, the use of the
placebo effect of caffeine may enhance fat oxidation during exercise in participants who
are aware of the benefits of caffeine but reduce any risks to health that this substance may
have [41]. This may be particularly useful in reducing typical side effects associated with
caffeine in an exercise setting such as insomnia and nervousness [42]. However, future
investigations are needed to determine if the placebo effect of caffeine on fat oxidation
can be obtained chronically, as it is probable that expectancy of receiving caffeine can be
reduced when an inert substance is administered for several days.
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